| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $8.96B | +19.4% |
| Cost of Revenue | $8.03B | +22.2% |
| R&D Expense | $37.0M | +8.8% |
| SG&A Expense | $246.0M | -0.4% |
| Operating Income | -$47.0M | +83.9% |
| Interest Expense | $104.0M | +4.0% |
| Pre-tax Income | -$192.0M | +58.2% |
| Income Tax | -$11.0M | +82.3% |
| Net Income | -$182.0M | +54.2% |
| EPS (Basic) | -$1.75 | +52.1% |
| EPS (Diluted) | -$1.75 | +52.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $261.0M | -22.1% |
| Accounts Receivable | $791.0M | -14.2% |
| Inventory | $1.62B | -0.5% |
| Current Assets | $3.00B | -5.2% |
| Total Assets | $6.01B | -8.6% |
| Current Liabilities | $1.97B | -4.5% |
| Long-term Debt | $1.60B | +0.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $338.0M | +183.0% |
| Capital Expenditures | $245.0M | +33.2% |
| Investing Cash Flow | -$214.0M | -18.2% |
| Financing Cash Flow | -$196.0M | -245.2% |
| Free Cash Flow | $93.0M | +115.7% |
| Total Liabilities |
| $4.66B |
| -7.2% |
| Stockholders' Equity | $1.36B | -12.2% |